Nordea Investment Management
AUPH icon

Nordea Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Nordea Investment Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.05M Buy
296,200
+4,000
+1% +$63.9K ﹤0.01% 605
2026
Q1 		$4.16M Sell
292,200
-12,000
-4% -$175K ﹤0.01% 631
2025
Q4 		$4.82M Sell
304,200
-54,900
-15% -$778K ﹤0.01% 594
2025
Q3 		$4.03M Buy
359,100
+4,100
+1% +$44.8K ﹤0.01% 636
2025
Q2 		$3.12M Buy
355,000
+5,400
+2% +$43.3K ﹤0.01% 650
2025
Q1 		$2.81M Buy
349,600
+11,000
+3% +$89.1K ﹤0.01% 639
2024
Q4 		$3.05M Buy
338,600
+1,000
+0.3% +$8.16K ﹤0.01% 620
2024
Q3 		$2.5M Sell
337,600
-12,300
-4% -$76.3K ﹤0.01% 654
2024
Q2 		$1.95M Buy
349,900
+41,400
+13% +$218K ﹤0.01% 702
2024
Q1 		$1.55M Buy
308,500
+105,100
+52% +$713K ﹤0.01% 749
2023
Q4 		$1.86M Sell
203,400
-11,100
-5% -$91.4K ﹤0.01% 723
2023
Q3 		$1.69M Buy
214,500
+2,100
+1% +$20.5K ﹤0.01% 723
2023
Q2 		$2.12M Buy
+212,400
New +$2.2M ﹤0.01% 690

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nordea Investment Management's AUPH Position: Q2 2026 in Review

Nordea Investment Management increased its Aurinia Pharmaceuticals (AUPH) stake by 1.4% in Q2 2026, buying an estimated $63.9K and bringing the position to 296,200 shares worth $5.05M. The position accounts for ﹤0.01% of the portfolio, ranked #605.

Nordea Investment Management first reported a position in AUPH in Q2 2023 and has held it in 13 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Nordea Investment Management held 296,200 shares of Aurinia Pharmaceuticals worth $5.05M as of Q2 2026.
  • Nordea Investment Management bought 4,000 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $63.9K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Nordea Investment Management's portfolio in Q2 2026, its #605 holding.
  • Nordea Investment Management first reported a position in Aurinia Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.